← Research LibraryThe BriefFY2026 10-K · headline figures audited against SEC data
Apogee revenue rose 3.2% in FY2026, but net income fell 36.4% as margins weakened.
The read at a glance✓ Audited against SEC data
- Business mix — Architectural products and servicesNote
- Revenue — Revenue rose 3.2% to $1.4BOK
- Profitability — Net income fell 36.4%Watch
- Cash — FCF rose 6.2%OK
- Balance sheet — Debt down; equity upOK
- Insiders — 0 buys / 0 sellsNote
- Accounting — Altman-Z grey; EQ safeNote
Business
Apogee provides architectural products and services for enclosing buildings, plus high-performance coating products for preservation, protection, and viewing applications.
Where the revenue comes from
Fiscal 2026, as APOGEE ENTERPRISES, INC. reports it. History and quarterly detail are in the app.
- Architectural Metals$504.0M
- Architectural Services$439.2M
- Architectural Glass$283.7M
- Performance Surfaces$198.0M
Leadership changes
From APOGEE ENTERPRISES, INC.'s own filings, the day they're filed.
- Brent C. Jewell · President · departureeff. 2026-05-26
- Matthew J. Osberg · Chief Financial Officer · departureeff. 2026-01-07
- Mark Augdahl · Chief Financial Officer · appointmenteff. 2026-01-07
Latest filings
- 8-K · Company announcement2026-09-03
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-07-01
- 10-Q · Quarterly report2026-06-30
- 8-K · Company announcement2026-06-29
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about APOGEE ENTERPRISES, INC., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.